Managing patients with new-onset dyspeptic symptoms represents a real chall
enge in clinical decision-making The major controversy has been over the op
timal management strategy of patients with new-onset dyspeptic symptoms who
do not present with alarm symptoms. Since unaided clinical diagnosis is un
reliable, proposed management strategies have included empirical treatment
algorithms, computer-assisted predictive score models and Helicobacter pylo
ri-based strategies such as test-and-scope or test-and-treat algorithms. En
doscopy remains the diagnostic 'gold standard', and the management should i
deally be based on endoscopic diagnosis. Because of economic constraints an
d increasing waiting lists, this is not possible. When precise and comprehe
nsive guidelines have been formulated, future patients will probably be man
aged in primary care by a Helicobacter test-and-treat policy, leaving only
empirical treatment failures for specialist evaluation.